Della Pasqua O - Search Results

1

Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy.

Santen G, Danhof M, Della Pasqua O. Santen G, et al. Among authors: della pasqua o. J Psychiatr Res. 2009 Aug;43(12):1049-56. doi: 10.1016/j.jpsychires.2009.02.001. Epub 2009 Apr 2. J Psychiatr Res. 2009. PMID: 19344914 Clinical Trial.

2

Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.

Santen G, Gomeni R, Danhof M, Della Pasqua O. Santen G, et al. Among authors: della pasqua o. J Psychiatr Res. 2008 Oct;42(12):1000-9. doi: 10.1016/j.jpsychires.2007.11.004. Epub 2008 Jan 18. J Psychiatr Res. 2008. PMID: 18206909

3

Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.

Santen G, Danhof M, Della Pasqua O. Santen G, et al. Among authors: della pasqua o. J Psychiatr Res. 2008 Oct;42(14):1189-97. doi: 10.1016/j.jpsychires.2007.11.009. Epub 2008 Mar 18. J Psychiatr Res. 2008. PMID: 18353370

4

The missing link between clinical endpoints and drug targets in depression.

Della Pasqua O, Santen GW, Danhof M. Della Pasqua O, et al. Trends Pharmacol Sci. 2010 Apr;31(4):144-52. doi: 10.1016/j.tips.2009.12.004. Epub 2010 Feb 1. Trends Pharmacol Sci. 2010. PMID: 20117847

5

A model-based approach to treatment comparison in acute migraine.

Maas HJ, Danhof M, Della Pasqua O. Maas HJ, et al. Among authors: della pasqua o. Br J Clin Pharmacol. 2006 Nov;62(5):591-600. doi: 10.1111/j.1365-2125.2006.02670.x. Br J Clin Pharmacol. 2006. PMID: 17061965 Free PMC article.

6

Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children.

Cella M, Danhof M, Della Pasqua O. Cella M, et al. Among authors: della pasqua o. Br J Clin Pharmacol. 2012 Aug;74(2):346-53. doi: 10.1111/j.1365-2125.2012.04187.x. Br J Clin Pharmacol. 2012. PMID: 22256787 Free PMC article.

7

Population pharmacokinetics of deferiprone in healthy subjects.

Bellanti F, Danhof M, Della Pasqua O. Bellanti F, et al. Among authors: della pasqua o. Br J Clin Pharmacol. 2014 Dec;78(6):1397-406. doi: 10.1111/bcp.12473. Br J Clin Pharmacol. 2014. PMID: 25052529 Free PMC article.

8

Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor.

Taneja A, Oosterholt SP, Danhof M, Della Pasqua O. Taneja A, et al. Among authors: della pasqua o. J Clin Pharmacol. 2016 May;56(5):609-21. doi: 10.1002/jcph.629. Epub 2015 Dec 27. J Clin Pharmacol. 2016. PMID: 26331692 Clinical Trial.

9

Model-Based Optimisation of Deferoxamine Chelation Therapy.

Bellanti F, Del Vecchio GC, Putti MC, Cosmi C, Fotzi I, Bakshi SD, Danhof M, Della Pasqua O. Bellanti F, et al. Among authors: della pasqua o. Pharm Res. 2016 Feb;33(2):498-509. doi: 10.1007/s11095-015-1805-0. Epub 2015 Nov 10. Pharm Res. 2016. PMID: 26555666 Free PMC article.

10

Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.

Piana C, Danhof M, Della Pasqua O. Piana C, et al. Among authors: della pasqua o. Expert Opin Drug Metab Toxicol. 2017 May;13(5):497-511. doi: 10.1080/17425255.2017.1277203. Epub 2017 Jan 23. Expert Opin Drug Metab Toxicol. 2017. PMID: 28043170 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page